AOD-9604 vs Pramlintide

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

AOD-9604 and Pramlintide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares AOD-9604 and Pramlintide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

AOD-9604Pramlintide
CategoryWeight Management & MetabolicWeight Management & Metabolic
Regulatory status (US)Research use onlyResearch use only
Typical dosage300 mcg60-120 mcg
Frequencydailywith meals
Reported benefitsFat metabolism, body composition improvement, no impact on blood sugar, cartilage repairReduced post-meal glucose, weight loss, appetite control
Reported side effectsMinimal side effects reportedNausea, hypoglycemia risk with insulin

Key differences

Primary use. AOD-9604 is categorised under Weight Management & Metabolic, while Pramlintide falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. AOD-9604: not FDA-approved; treated as a research compound. Pramlintide: not FDA-approved; treated as a research compound.

Dosing. AOD-9604 is typically dosed at 300 mcg (daily). Pramlintide is typically dosed at 60-120 mcg (with meals).

Can you stack them?

Some protocols combine peptides, but stacking AOD-9604 and Pramlintide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between AOD-9604 and Pramlintide?
AOD-9604 and Pramlintide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. AOD-9604 is not FDA-approved; generally classified as a research compound, whereas Pramlintide is not FDA-approved; generally classified as a research compound.
What is AOD-9604 used for?
Fat loss, metabolic enhancement.
What is Pramlintide used for?
Amylin analog for diabetes.
Can you take AOD-9604 and Pramlintide together?
Some users combine peptides within a single protocol, but stacking AOD-9604 and Pramlintide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is AOD-9604 or Pramlintide FDA-approved?
AOD-9604 is not FDA-approved; generally classified as a research compound. Pramlintide is not FDA-approved; generally classified as a research compound.

Read the full articles

  • AOD-9604 — full monograph: mechanism, research, dosing & references
  • Pramlintide — full monograph: mechanism, research, dosing & references

More Weight Management & Metabolic comparisons

← All peptide comparisons